Atropine Sulfate Injection — FDA Drug Shortage

Current — Accord Healthcare Inc.

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Accord Healthcare Inc. with status Current. The shortage was first posted on Jan 1, 2020. Reported reason: Discontinuation of the manufacture of the drug

Shortage details

Status
Current
Company
Accord Healthcare Inc.
Package NDC
16729-484-90
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)
Initial Posting
Jan 1, 2020

Reason

Discontinuation of the manufacture of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.